Supplementary Table S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

<p>Supplementary Table S5. Complete listing and details of siRNA targeting sequences used for gene knockdown in Fig. 4A and Extended Data Fig. 3.</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Chuandong Geng (17315310) (author)
Diğer Yazarlar:	Man-Chao Zhang (17315313) (author), Ganiraju C. Manyam (17315316) (author), Jody V. Vykoukal (17315319) (author), Johannes F. Fahrmann (15052230) (author), Shan Peng (17315322) (author), Cheng Wu (17315325) (author), Sanghee Park (17315328) (author), Shakuntala Kondraganti (17315331) (author), Daoqi Wang (17315334) (author), Brian D. Robinson (16755326) (author), Massimo Loda (14958363) (author), Christopher E. Barbieri (15012150) (author), Timothy A. Yap (15028749) (author), Paul G. Corn (17315337) (author), Samir Hanash (17314360) (author), Bradley M. Broom (15022580) (author), Patrick G. Pilié (15119957) (author), Timothy C. Thompson (17315340) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Cell Signaling DNA Damage and Repair Drug Mechanisms Genitourinary Cancers Prostate cancer Small Molecule Agents
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller